Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

AIDS

Volumn 27, Issue 6, 2013, Pages 981-989

  Abu Raddad, Laith J ^a,b,c   Barnabas, Ruanne V ^c   Janes, Holly ^c   Weiss, Helen A ^e   Kublin, James G ^c   Longini Jr , Ira M ^f   Wasserheit, Judith N ^c,d  

^a Department of Obstetrics Gynecology   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Clinical Research Division   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Co infection; Epidemic; HIV; Mathematical model; Sub Saharan Africa; Viral load

Indexed keywords

VIRUS RNA;

ADULT; AFRICA; ARTICLE; ASIA; COHORT ANALYSIS; DATA BASE; EPIDEMIC; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOUTH AMERICA; STATISTICAL MODEL; VIRUS LOAD; VIRUS TRANSMISSION;

AFRICA SOUTH OF THE SAHARA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MODELS, THEORETICAL; PREGNANCY; RNA, VIRAL; VIRAL LOAD;

EID: 84876414426     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835cb927     Document Type: Article

References (38)

1. UNAIDS. UNAIDS 2011 World AIDS Day Report (available at) http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/ 2011/JC2216-WorldAIDSday-report-2011-en.pdf [Accessed 3 January 2012]. 2011.
2. Pettifor AE, Levandowski BA, Macphail C, Miller WC, Tabor J, Ford C, et al. A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health 2011; 49:237e231-243e231.
3. Morris M. Sexual networks and HIV. AIDS 1997; 11:S209- S216.
4. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006; 314:1603-1606.
5. Kaul R, Cohen CR, Chege D, Yi TJ, Tharao W, McKinnon LR, et al. Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol 2011; 65:317-324.
6. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001; 17:901- 910.
7. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153.
8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493- 505.
9. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5:e11068.
10. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li CJ, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929.
11. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 2010; 5:e12598.
12. Nguyen RHN, Gange SJ, Serwadda D, Wabwire-Mangen F, Sewankambo KN, Wawer M, et al. Reduced odds of livebirth associated with HIV-RNA viral load: Rakai, Uganda In: XIV International AIDS Conference: Barcelona: International AIDS Society, Stockholm; 2002: 395.
13. Bruce-Chwatt LJ. A Longitudinal Survey of Natural Malaria Infection in a Group of West African Adults. West Afr Med J 1963; 12:199-217.
14. Rogier C, Ly AB, Tall A, Cisse B, Trape JF. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg 1999; 60:410-420.
15. Snow RW, Craig MH, Newton CR, Steketee RW. The public health burden of Plasmodium falciparum malaria in Africa: Deriving the numbers, Working Paper No. 11, Disease Control Priorities Project, Bethesda, Maryland: Fogarty International Center, National Institutes of Health, http://mednet3.who.int/ prioritymeds/report/append/610snow-wp11.pdf. In; 2003.
16. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: A prospective cohort study. Lancet 2005; 365:233-240.
17. Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang ML, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008; 198:1141-1149.
18. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM Jr, Self SG, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008; 3:e2230.
19. Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: A literature review. Bull World Health Organ 2004; 82:462-469.
20. Morgan D, Mahe C, Mayanja B, Whitworth JA. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ 2002; 324:193-196.
21. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434:214-217.
22. Casteling A, Sim J, Williamson C, Loubser S, van Brummelen R, Napier G, Martin D. Comparison of viral load technologies for samples from South African patients. In: AIDS 2000. Durban; 2000.
23. Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of coinfections in HIV epidemic trajectory and positive prevention: A systematic review and meta-analysis. AIDS 2011; 25:1559-1573.
24. Rizzardini G, Piconi S, Ruzzante S, Fusi ML, Lukwiya M, Declich S, et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 1996; 10:1535-1542.
25. Kalinkovich A, Weisman Z, Leng Q, Borkow G, Stein M, Greenberg Z, et al. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa. J Hum Virol 1999; 2:283-289.
26. Cohen CR, Moscicki AB, Scott ME, Ma Y, Shiboski S, Bukusi E, et al. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010; 24:2069-2074.
27. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005; 191:1391- 1393.
28. Novitsky V, Ndung'u T, Wang R, Bussmann H, Chonco F, Makhema J, et al. Extended high viremics: A substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS 2011; 25:1515- 1522.
29. Emery S, Bodrug S, Richardson BA, Giachetti C, Bott MA, Panteleeff D, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-2695.
30. Dyer JR, Kazembe P, Vernazza PL, Gilliam BL, Maida M, Zimba D, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998; 177:1742-1746.
31. Gras L, Jurriaans S, Bakker M, van Sighem A, Bezemer D, Fraser C, et al. Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One 2009; 4:e7365.
32. Muller V, von Wyl V, Yerly S, Boni J, Klimkait T, Burgisser P, et al. African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS 2009; 23:1269-1276.
33. Cuadros DF, Branscum AJ, Crowley PH. HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub- Saharan Africa. Int J Epidemiol 2011; 40:931-939.
34. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
35. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010; 375:2092-2098.
36. Walson JL. Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression (THE or PHE), 2008. See http://clinicaltrials.gov/show/ NCT00507221 [Accessed 10 January 2013].
37. Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS 2010; 24 (Suppl 4):S15-S26.
38. Tanton C, Abu-Raddad LJ, Weiss HA. Time to refocus on HSV interventions for HIV prevention? J Infect Dis 2011; 204:1822- 1826.